0.00Open0.00Pre Close0 Volume0 Open Interest175.00Strike Price0.00Turnover0.00%IV-30.31%PremiumDec 20, 2024Expiry Date40.70Intrinsic Value100Multiplier-4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Tradeweb Markets Stock Discussion
$BILL Holdings (BILL.US)$ $Perion Network (PERI.US)$ $Fiverr International (FVRR.US)$ $CubeSmart (CUBE.US)$ $DocuSign (DOCU.US)$ $Tradeweb Markets (TW.US)$ $Everest Group (EG.US)$
$Tradeweb Markets (TW.US)$ initiated at overweight by Barclays, announced targe price at $89.00.
$Pinterest (PINS.US)$ was upgraded by Wells Fargo from equal-weight to overweight, increased target price from $23.00 to $34.00.
$Beazer Homes USA (BZH.US)$ was upgraded by Wedbush from neutral to outperform.
$Uber Technologies (UBER.US)$ was downgraded by Daiwa Capi...
Semiconductor stocks were down in general, with the Philadelphia Semiconductor Index falling 1.62% overnight. TSMC fell 0.94%, UMC fell 1.11% and wireless communication chip company MediaTek fell 2.68%.
Among them, TSMC sources on Thursday suggested that because production capacity can not keep up with demand, car compa...
China views the visit by Pelosi, a long-time critic of Beijing, as sending an encouraging signal to the pro-independence camp in Taiwan and has repeatedly warned agai...
Tesla $Tesla (TSLA.US)$ was a big winner last week, rebounding powerfully from the top of a prior base to clear its 50-day line. But Tesla stock isn't in buy range yet. Meanwhile Tradeweb Markets $Tradeweb Markets (TW.US)$ , ArcBest (ARCB), Advanced Micro Devices $Advanced Micro Devices (AMD.US)$ , West Pharmaceutical Services $West Pharmaceutical Services (WST.US)$ and Google stock all are actionable now.
Tesla, Google, AMD and TW stock are on IBD Leaderboard. Google stock is on SwingTrader. Google and WST stock are on IBD Long-Term Leaders. Google, West Pharma, Tradeweb and AMD stock are on the IBD 50. Tradeweb also is IBD Stock Of The Day.
Part of the content is taken from Investor.
No comment yet